Skip to main content
Erschienen in: Diabetology & Metabolic Syndrome 1/2012

Open Access 01.12.2012 | Letter to the Editor

Evaluating the mitochondrial function

verfasst von: Emin Ozgur Akgul, Mehmet Toygar, Yavuz Poyrazoglu

Erschienen in: Diabetology & Metabolic Syndrome | Ausgabe 1/2012

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
Hinweise

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

Dr. EO AKGUL, MD is the corresponding author of this letter. He evaluated that paper from biochemical aspect. Dr MT, MD is specialist of forensic medicine. He evaluated that paper form morphological aspect. Dr. YP is specialist of general surgery. He drafted the letter. All authors read and approved the final manuscript.

Dear Editor

We have read the article by Xia et.al. entitled as "L-carnitine ameliorated fatty liver in high-calorie diet/STZ induced type 2 diabetic mice by improving mitochondrial function" with great interest [1]. In this article, the authors concluded that L-carnitine might be an effective liver cell protector for delaying the progression of type 2 diabetes mellitus complications. They supported this conclusion by using biochemical and morphological differences between control and L-carnitine-treated groups. However, we have some reservations the terms they used throughout the article: Firstly, the term of "mitochondrial function" has a very broad meaning and might be a little bit confusing as well. As known, mitochondria basically have three biochemical systems: i) β-oxidation, ii) tricarboxylic acid cycle (TCA cycle) and iii) electron transport chain. Although all these systems are interconnected and coexist in mitochondria at the same time, only dysfunctions of electron transport chain are enumerated among the mitochondrial diseases. In this article, we understand that the mitochondrial complex activities were not measured at all. Therefore, we think that the conclusion saying "L-carnitine stimulates fat metabolism" is acceptable. But, using the term of "improvement of mitochondrial function" in this context is not scientifically very appropriate. Secondly, the authors did not describe the method(s) they used in "morphological assessment of hepatic tissue" in detail. They said that tissue samples have been fixed in 4% paraformaldehyde in the third page of the paper. But, as far as we know, oil red O staining works only with fresh frozen tissues. Besides, the red dots in figure 2 were presented as lipid droplets. If these are lipid droplets, then the other unstained vacuoles in the same figure were remained to be identified. We think that the tissues stained with oil red O must be fresh-frozen samples, and at least some of that unstained vacuoles were actually freezing artifacts. Discrimination between freezing artifacts and lipid vacuoles are important because the authors assumed that L-carnitine was decreasing "lipid area percentage" in hepatic tissue.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

Dr. EO AKGUL, MD is the corresponding author of this letter. He evaluated that paper from biochemical aspect. Dr MT, MD is specialist of forensic medicine. He evaluated that paper form morphological aspect. Dr. YP is specialist of general surgery. He drafted the letter. All authors read and approved the final manuscript.
download
DOWNLOAD
print
DRUCKEN
Literatur
1.
Zurück zum Zitat Xia Y, Li Q, Zhong W, Dong J, Wang Z, Wang C: L-carnitine ameliorated fatty liver in high-calorie diet/STZ-induced type 2 diabetic mice by improving mitochondrial function. Diabetol Metab Syndr. 2011, 3: 31-10.1186/1758-5996-3-31.PubMedCentralCrossRefPubMed Xia Y, Li Q, Zhong W, Dong J, Wang Z, Wang C: L-carnitine ameliorated fatty liver in high-calorie diet/STZ-induced type 2 diabetic mice by improving mitochondrial function. Diabetol Metab Syndr. 2011, 3: 31-10.1186/1758-5996-3-31.PubMedCentralCrossRefPubMed
Metadaten
Titel
Evaluating the mitochondrial function
verfasst von
Emin Ozgur Akgul
Mehmet Toygar
Yavuz Poyrazoglu
Publikationsdatum
01.12.2012
Verlag
BioMed Central
Erschienen in
Diabetology & Metabolic Syndrome / Ausgabe 1/2012
Elektronische ISSN: 1758-5996
DOI
https://doi.org/10.1186/1758-5996-4-11

Weitere Artikel der Ausgabe 1/2012

Diabetology & Metabolic Syndrome 1/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

VHF-Ablation nützt wohl nur bei reduzierter Auswurfleistung

02.05.2024 Ablationstherapie Nachrichten

Ob die Katheterablation von Vorhofflimmern bei Patienten mit Herzinsuffizienz die Komplikationsraten senkt, scheint davon abzuhängen, ob die Auswurfleistung erhalten ist oder nicht. Das legen die Ergebnisse einer Metaanalyse nahe.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.